These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11110693)

  • 1. Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery.
    Eitzman DT; Westrick RJ; Xu Z; Tyson J; Ginsburg D
    Blood; 2000 Dec; 96(13):4212-5. PubMed ID: 11110693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice.
    Zhu Y; Farrehi PM; Fay WP
    Circulation; 2001 Jun; 103(25):3105-10. PubMed ID: 11425776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1.
    Sjöland H; Eitzman DT; Gordon D; Westrick R; Nabel EG; Ginsburg D
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):846-52. PubMed ID: 10712412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of urokinase plasminogen activator promotes progression and instability of atherosclerotic lesions in apolipoprotein E-knockout mice.
    Dellas C; Schremmer C; Hasenfuss G; Konstantinides SV; Schäfer K
    Thromb Haemost; 2007 Jul; 98(1):220-7. PubMed ID: 17598016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
    Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries.
    DeYoung MB; Tom C; Dichek DA
    Circulation; 2001 Oct; 104(16):1972-1. PubMed ID: 11602503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1.
    Schafer K; Müller K; Hecke A; Mounier E; Goebel J; Loskutoff DJ; Konstantinides S
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2097-103. PubMed ID: 14512369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.
    Selle J; Asare Y; Köhncke J; Alampour-Rajabi S; Shagdarsuren G; Klos A; Weber C; Jankowski J; Shagdarsuren E
    Thromb Haemost; 2015 Oct; 114(4):848-58. PubMed ID: 26084965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice.
    Eitzman DT; Westrick RJ; Nabel EG; Ginsburg D
    Blood; 2000 Jan; 95(2):577-80. PubMed ID: 10627465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
    Zhu Y; Carmeliet P; Fay WP
    Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice.
    Westrick RJ; Bodary PF; Xu Z; Shen YC; Broze GJ; Eitzman DT
    Circulation; 2001 Jun; 103(25):3044-6. PubMed ID: 11425765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deletion of tissue-type plasminogen activator (t-PA) in APOE3-Leiden mice reduces progression of cholesterol-induced atherosclerosis.
    Rezaee F; Gijbels M; Offerman E; Verheijen J
    Thromb Haemost; 2003 Oct; 90(4):710-6. PubMed ID: 14515193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
    Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
    Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice.
    Li X; Chyu KY; Faria Neto JR; Yano J; Nathwani N; Ferreira C; Dimayuga PC; Cercek B; Kaul S; Shah PK
    Circulation; 2004 Sep; 110(12):1701-5. PubMed ID: 15353488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice.
    Bonthu S; Heistad DD; Chappell DA; Lamping KG; Faraci FM
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2333-40. PubMed ID: 9409199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice.
    Luttun A; Lupu F; Storkebaum E; Hoylaerts MF; Moons L; Crawley J; Bono F; Poole AR; Tipping P; Herbert JM; Collen D; Carmeliet P
    Arterioscler Thromb Vasc Biol; 2002 Mar; 22(3):499-505. PubMed ID: 11884297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis.
    Xiao Q; Danton MJ; Witte DP; Kowala MC; Valentine MT; Bugge TH; Degen JL
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10335-40. PubMed ID: 9294211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.
    Diaz JA; Ballard-Lipka NE; Farris DM; Hawley AE; Wrobleski SK; Myers DD; Henke PK; Lawrence DA; Wakefield TW
    J Vasc Surg; 2012 Mar; 55(3):815-22. PubMed ID: 22119245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced atherothrombotic formation after oxidative injury by FeCl3 to the common carotid artery in severe combined hyperlipidemic mice.
    Xian X; Ding Y; Zhang L; Wang Y; McNutt MA; Ross C; Hayden MR; Deng X; Liu G
    Biochem Biophys Res Commun; 2009 Aug; 385(4):563-9. PubMed ID: 19481534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.